Citation Impact
Citing Papers
Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis
2010
Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
2014
Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States
2014
Reactivity of (1→3)-β- d -Glucan Assay with Commonly Used Intravenous Antimicrobials
2006
Paradoxical echinocandin activity: a limitedin vitrophenomenon?
2009
Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance
2004
Combination antifungal therapy: From bench to bedside
2008
Final adult height and body mass index after cure of paediatric Cushing's disease
2005
GROWTH SUPPRESSION BY GLUCOCORTICOID THERAPY
1996
Mechanisms of Thrombus Formation
2008 Standout
Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases
2009
False-Positive Results of Aspergillus Galactomannan Antigenemia in Liver Transplant Recipients
2009
Vulvovaginal candidosis
2007 Standout
Opportunistic Mycoses in the Immunocompromised Host: Experience at a Cancer Center and Review
1992
A Randomized Trial of Prenatal versus Postnatal Repair of Myelomeningocele
2011 Standout
Photodynamic Therapy
1998 Standout
Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions
2013 StandoutNature
Galactomannan Antigenemia in Pediatric Oncology Patients With Invasive Aspergillosis
2008
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
1999 Standout
Candida Urinary Tract Infections—Diagnosis
2011
Toward more effective antifungal therapy: the prospects of combination therapy
2004
Anti-PMP22 antibodies in patients with inflammatory neuropathy
2000
Approach to the Diagnosis of Invasive Aspergillosis and Candidiasis
2009
CNS pharmacokinetics of antifungal agents
2007
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Glucan synthase inhibitors as antifungal agents
2001
The concentration-dependent nature of in vitro amphotericin B–itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions
2006
Reviews Of Anti‐infective Agents: Anidulafungin: A Novel Echinocandin
2006
Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
1995
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
The status of gene therapy for brain tumors
2007
Biomarkers in experimental models of antibody‐mediated neuropathies
2011
Diagnosis and Management of Fungal Urinary Tract Infection
2013
Cushing's syndrome
2015 Standout
Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign
2007
Guillain-Barré syndrome
2016 Standout
Candida Endophthalmitis: Focus on Current and Future Antifungal Treatment Options
2007
Evolving Role of Flucytosine in Immunocompromised Patients: New Insights into Safety, Pharmacokinetics, and Antifungal Therapy
1992
Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
1995 StandoutNature
Guillain–Barré Syndrome
2012 Standout
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
1999
The REDCap consortium: Building an international community of software platform partners
2019 Standout
The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental HematogenousCandidaMeningoencephalitis: Implications for Echinocandin Therapy in Neonates
2007
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis
2006
Hepatosplenic candidiasis: Successful treatment with fluconazole
1991
The biology of VEGF and its receptors
2003 Standout
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
2003
Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis
2013
Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases
2004
Candida Urinary Tract Infections—Treatment
2011
Utility of (1–3)-β-d-Glucan Testing for Diagnostics and Monitoring Response to Treatment During the Multistate Outbreak of Fungal Meningitis and Other Infections
2013
Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy
1995
Antifungal Combination Therapy for Invasive Aspergillosis
2014
Posaconazole: clinical pharmacology and potential for management of fungal infections
2005
Strong Correlation between Serum Aspergillus Galactomannan Index and Outcome of Aspergillosis in Patients with Hematological Cancer: Clinical and Research Implications
2008
The behavioral pharmacology of hallucinogens
2007
Developmental regulation of the growth plate
2003 StandoutNature
Spina bifida
2004
Invasive Aspergillosis in Transplant Recipients
1999
5-HT and alcohol abuse
1992
Issues with galactomannan testing
2006
Regulation of ciliary neurotrophic factor expression in myelin-related Schwann cells in vivo
1992
Newer Systemic Antifungal Agents
2004
Efficacy of DNA amplification in tissue biopsy samples to improve the detection of invasive fungal disease
2012
Echinocandin antifungal drugs
2003 Standout
Efficacy of Unilamellar Liposomal Amphotericin B in Treatment of Pulmonary Aspergillosis in Persistently Granulocytopenic Rabbits: The Potential Role of Bronchoalveolar D-Mannitol and Serum Galactomannan as Markers of Infection
1994
Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in ExperimentalCandida albicansInfection of the Central Nervous System
2000
A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT
2008
Asthma
2001 Standout
Malignant Gliomas in Adults
2008 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Galactomannan Does Not Precede Major Signs on a Pulmonary Computerized Tomographic Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies
2005
Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy
1991
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
2004
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
1996
Candida glabrata Endophthalmitis Treated Successfully with Caspofungin
2005
Dexamethasone Induces Apoptosis in Proliferative Chondrocytes through Activation of Caspases and Suppression of the Akt-Phosphatidylinositol 3′-Kinase Signaling Pathway
2004
Management of Invasive Candidal Infections: Results of a Prospective, Randomized, Multicenter Study of Fluconazole Versus Amphotericin B and Review of the Literature
1996
Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New Definition
2011
The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review
2011
Candiduria
2005
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints
2009
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
2000
Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation
2004
Serum galactomannan in cystic fibrosis patients colonized withAspergillusspecies
2012
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
2006
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations
2006
Intravenous antibiotics reduce the presence ofAspergillusin adult cystic fibrosis sputum
2013
Peripheral neuropathies and anti-glycolipid antibodies
2002
Prevention and Early Treatment of Invasive Fungal Infection in Patients with Cancer and Neutropenia and in Stem Cell Transplant Recipients in the Era of Newer Broad-Spectrum Antifungal Agents and Diagnostic Adjuncts
2007
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis
2002
A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis
2005
A Randomized Double‐Blind Study of Caspofungin versus Amphotericin for the Treatment of Candidal Esophagitis
2001
Age and pattern of the onset of differential growth among growth plates in rats
2008
Advances and challenges in management of invasive mycoses
2005
Treatment of Endogenous Fungal Endophthalmitis: Focus on New Antifungal Agents
2011
Ocular penetration of caspofungin in a rabbit uveitis model
2006
Fluconazole versus Amphotericin B in the treatment of Hematogenous Candidiasis: A matched cohort study
1996
Galactomannan in Bronchoalveolar Lavage Fluid
2007
Candiduria in Hospital Patients: A Study Prospective
2004
Posaconazole as Salvage Therapy in Patients with Chronic Granulomatous Disease and Invasive Filamentous Fungal Infection
2005
New antifungal agents under development in children and neonates
2005
Th1/Th2 in aspergillosis
2006
Pacemaker Endocarditis Due to Candida albicans: Case Report and Review
1997
Evaluation of Serum Sandwich Enzyme-Linked Immunosorbent Assay for Circulating Galactomannan during Caspofungin Therapy: Results from the Caspofungin Invasive Aspergillosis Study
2005
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B
2003
Preclinical Evaluation of Pharmacotherapies for Treatment of Cocaine and Opioid Abuse Using Drug Self-Administration Procedures
1996
Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center
2011
The molecular neurobiology of depression
2008 StandoutNature
Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates
2009
Micafungin: A New Echinocandin
2006
HEPATOSPLENIC CANDIDIASIS
2000
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
2002
Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis
2008
(1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
2012
Subtherapeutic Ocular Penetration of Caspofungin and Associated Treatment Failure in Candida albicans Endophthalmitis
2005
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Guillain-Barré syndrome
2005 Standout
Changes in thymic function with age and during the treatment of HIV infection
1998 StandoutNature
Canine Models of Gene-Modified Hematopoiesis
2009
Issues Related to the Design and Interpretation of Clinical Trials of Salvage Therapy for Invasive Mold Infection
2006
Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants
2009
Nonfilamentous C. albicans Mutants Are Avirulent
1997 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Magnetic resonance imaging is superior to computed tomography and ultrasonography in imaging infectious liver foci in acute leukaemia
1996
In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida , Aspergillus , Fusarium , and Scedosporium Species
2008
CNS pharmacokinetics of antifungal agents
2007
Quantitative PCR Assay To Measure Aspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate
2001
Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
2009
Dosage-Dependent Antifungal Efficacy of V-Echinocandin (LY303366) against Experimental Fluconazole-Resistant Oropharyngeal and Esophageal Candidiasis
2001
Diagnosis of Invasive Fungal Disease Using Serum (1.RAR.3)-.BETA.-D-Glucan: A Bivariate Meta-Analysis
2011
Prognostic value of serum galactomannan index in critically ill patients with chronic obstructive pulmonary disease at risk of invasive pulmonary aspergillosis
2014
Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in Rabbits
2001
Combination Treatment of Invasive Fungal Infections
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart.
1995
Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected withAspergillusSpecies and Other Filamentous Fungi: Maximum Tolerated Dose Study
2001
Ocular Distribution of Intravenously Administered Lipid Formulations of Amphotericin B in a Rabbit Model
2002
Detection of Galactomannan in Bronchoalveolar Lavage Fluid Samples of Patients at Risk for Invasive Pulmonary Aspergillosis: Analytical and Clinical Validity
2012
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
2012
Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans
1999
Reactive Oxygen Species‐Scavenging Nanomedicines for the Treatment of Oxidative Stress Injuries
2014
Antifungal agents: chemotherapeutic targets and immunologic strategies
1996
Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole
1995
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis
1997
Pharmacological Approaches for the Treatment of Obesity
2002
Lymphocyte Homing and Homeostasis
1996 StandoutScience
Antifungal Activity of LY303366, a Novel Echinocandin B, in Experimental Disseminated Candidiasis in Rabbits
1999
Defective thrombus formation in mice lacking coagulation factor XII
2005
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia
2002
Laboratory diagnosis of invasive aspergillosis
2005
Combination Antifungal Therapy
2004
PUTATIVE VIRULENCE FACTORS OF CANDIDA ALBICANS
1991
Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state
2000
Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections
2006
AspergillusInfections in Transplant Recipients
2005
New targets and delivery systems for antifungal therapy
2000
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The Antifungal Echinocandin Caspofungin Acetate Kills Growing Cells of Aspergillus fumigatus In Vitro
2002
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
AspergillusGalactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid
2004
Nanoparticles in Photodynamic Therapy
2015 Standout
Reprogramming homing endonuclease specificity through computational design and directed evolution
2013 StandoutNobel
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
Posaconazole: A Next-Generation Triazole Antifungal
2007
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Fluconazole Prophylaxis in Extremely Low Birth Weight Neonates Reduces Invasive Candidiasis Mortality Rates Without Emergence of Fluconazole-Resistant Candida Species
2008
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
Growth hormone status following treatment for Cushing's syndrome
1999
Pharmacokinetics and Pharmacodynamics of Anidulafungin for Experimental Candida Endophthalmitis: Insights into the Utility of Echinocandins for Treatment of a Potentially Sight-Threatening Infection
2012
Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Disseminated Candidiasis and Aspergillosis
2000
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Efficacy of combination therapy of triazole and echinocandin in treatment of invasive aspergillosis: a systematic review of animal and human studies.
2014
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
2013
Pharmacokinetic and Pharmacodynamic Modeling of Anidulafungin (LY303366): Reappraisal of Its Efficacy in Neutropenic Animal Models of Opportunistic Mycoses Using Optimal Plasma Sampling
2001
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
Compartmental Pharmacokinetics of the Antifungal Echinocandin Caspofungin (MK-0991) in Rabbits
2001
Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia
2001
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy
2012 Standout
In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi
2000
Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases
2002
Candida Infections of the Genitourinary Tract
2010
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice
1992
Emerging Targets in Photopharmacology
2016 StandoutNobel
Systemic and Local Regulation of the Growth Plate
2003
T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny
1993
Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients
2005
Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits
1991
Efficacies of Two New Antifungal Agents, the Triazole Ravuconazole and the Echinocandin LY-303366, in an Experimental Model of Invasive Aspergillosis
2000
Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real‐life combo study
2013
Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B
2010
Fungicidal Activity of Fluconazole against Candida albicans in a Synthetic Vagina-Simulative Medium
2003
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Efficacy of FK463, a New Lipopeptide Antifungal Agent, in Mouse Models of Pulmonary Aspergillosis
2000
Combination Antifungal Therapy for Invasive Aspergillosis
2015
Connexin Mutations in X-Linked Charcot-Marie-Tooth Disease
1993 StandoutScience
Bifidobacterial Lipoglycan as a New Cause for False-Positive Platelia Aspergillus Enzyme-Linked Immunosorbent Assay Reactivity
2005
Works of John Bacher being referenced
Characterization and Comparison of Galactomannan Enzyme Immunoassay and Quantitative Real-Time PCR Assay for Detection of Aspergillus fumigatus in Bronchoalveolar Lavage Fluid from Experimental Invasive Pulmonary Aspergillosis
2006
CARDIAC ALLOGRAFT SURVIVAL ACROSS MAJOR HISTOCOMPATIBILITY COMPLEX BARRIERS IN THE RHESUS AUTOLOGOUS MARROW TRANSPLANTATION MONKEY FOLLOWING T LYMPHOCYTE-DEPLETED
1989
Experimental Pulmonary Aspergillosis Due toAspergillus terreus:Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B
2003
Effects of Preventive, Early, and Late Antifungal Chemotherapy with Fluconazole in Different Granulocytopenic Models of Experimental Disseminated Candidiasis
1990
The expression of myelin-associated glycoprotein in regenerating cat sciatic nerve
1988
Triazole‐Polyene Antagonism in Experimental Invasive Pulmonary Aspergillosis: In Vitro and In Vivo Correlation
2006
RECOMBINANT HUMAN MACROPHAGE COLONY-STIMULATING FACTOR AUGMENTS PULMONARY HOST DEFENCES AGAINST ASPERGILLUS FUMIGATUS
2001
Hemodynamic effect of the nitroxide superoxide dismutase mimics
1999
Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits
2005
Selective anorexigenic effects of corticotropin releasing hormone in the rhesus monkey
1991
Effect of Ganglion Blockade on Cerebrospinal Fluid Norepinephrine
1987
Intrathoracic photodynamic therapy: A canine normal tissue tolerance study and early clinical experience
1994
Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: Synergistic Interaction between an Antifungal Triazole and an Echinocandin
2003
Evaluation of Single-Drug and Combination Antifungal Therapy in an Experimental Model of Candidiasis in Rabbits with Prolonged Neutropenia
1988
Demyelination induced by intraneural injection of human antimyelin‐associated glycoprotein antibodies
1988
In vivo bypass of hemophilia A coagulation defect by Factor XIIa implant
2000
Experimental Basis for Use of Fluconazole for Preventive or Early Treatment of Disseminated Candidiasis in Granulocytopenic Hosts
1990
Catch-up growth after glucocorticoid excess: a mechanism intrinsic to the growth plate.
1994
Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics
1999
Nonmyeloablative Conditioning with Busulfan before Matched Littermate Bone Marrow Transplantation Results in Reversal of the Disease Phenotype in Canine Leukocyte Adhesion Deficiency
2005
Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis
2015
Lactate-induced electrolyte changes in the cerebrospinal fluid of rabbits
1990
Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy
1995
Dose-Dependent Pharmacokinetics of Amphotericin B Lipid Complex in Rabbits
2000
Cerebrospinal Fluid and Plasma (1→3)-β-d -Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental HematogenousCandidaMeningoencephalitis
2008
Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey
1986
Antifungal Efficacy, Safety, and Single-Dose Pharmacokinetics of LY303366, a Novel Echinocandin B, in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits
1998
Toxicity studies and distribution dynamics of retroviral vectors following intrathecal administration of retroviral vector-producer cells.
1995
Molecular Detection and Species-Specific Identification of Medically Important Aspergillus Species by Real-Time PCR in Experimental Invasive Pulmonary Aspergillosis
2011
SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits
1990
Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine.
1995
Dose-Dependent Pharmacokinetics of Amphotericin B Lipid Complex in Rabbits
2000
Antifungal Activity of the Pradimicin Derivative BMS 181184 in the Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits
1998
Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic Rabbits
2002
Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits.
1988
Induction of growth plate cartilage ossification by basic fibroblast growth factor.
1994
Functional and Anatomic Recovery in the Monkey Brain following Excision of Fetal Encephalocele
1985
Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits
1992
Detection of a Molecular Biomarker for Zygomycetes by Quantitative PCR Assays of Plasma, Bronchoalveolar Lavage, and Lung Tissue in a Rabbit Model of Experimental Pulmonary Zygomycosis
2008
Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits
2004
Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis
1991
The Role of the Resting Zone in Growth Plate Chondrogenesis
2002
Use of subcutaneous vascular access ports in rhesus monkeys.
1994
The Initial 96 Hours of Invasive Pulmonary Aspergillosis: Histopathology, Comparative Kinetics of Galactomannan and (1→3)-β- d -Glucan, and Consequences of Delayed Antifungal Therapy
2010
Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose- Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis
2009
Galactomannan Antigenemia after Infusion of Gluconate-Containing Plasma-Lyte
2011
Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction
2004
Compartmentalized Intrapulmonary Pharmacokinetics of Amphotericin B and Its Lipid Formulations
2006
Correlation between In Vitro and In Vivo Antifungal Activities in Experimental Fluconazole-Resistant Oropharyngeal and Esophageal Candidiasis
2000
Quantitative urine cultures do not reliably detect renal candidiasis in rabbits
1997
Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine.
1995
Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits
1994